The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions

BACKGROUND: Despite the growing application of facilitated regulatory pathways (FRPs), little attention has focused on assessing the perception of pharmaceutical companies regarding their usefulness beyond increasing timeliness. OBJECTIVES: The aim of this study was to characterize the perceived val...

Descripción completa

Detalles Bibliográficos
Autores principales: Bujar, Magdalena, McAuslane, Neil, Liberti, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858039/
https://www.ncbi.nlm.nih.gov/pubmed/33537899
http://dx.doi.org/10.1007/s40290-020-00372-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858039/
https://www.ncbi.nlm.nih.gov/pubmed/33537899
http://dx.doi.org/10.1007/s40290-020-00372-7

Ejemplares similares